Where is the live CopyMark page for USPTO serial 85741219?

The live record is at https://getcopymark.com/trademark/85741219. Use https://getcopymark.com/trademark/{serialNumber} for any 8-digit USPTO serial.

Who owns THERAFLIXIMAB?

According to the public USPTO record for serial number 85741219, the listed owner(s) include: TPI, TPI.

What is USPTO serial number 85741219?

Serial number 85741219 is the USPTO application identifier for the mark THERAFLIXIMAB. It is used to track examination, publication, and registration of this trademark.

What is the current status of THERAFLIXIMAB?

THERAFLIXIMAB (85741219) currently shows USPTO status code 605 on the public record. This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Which trademark classes cover THERAFLIXIMAB?

The public record lists International Classes: 005. Each class corresponds to categories of goods or services identified in the application or registration.

Trademark: THERAFLIXIMAB Serial# 85741219 | status 605; last event MAB5 | Trademark Info & Attorney Guidance

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with THERAFLIXIMAB?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner

Monitor this mark, or talk with CopyMark about this registration.

Trademark Monitoring

(312) 319-4460

Not the owner?

File a new U.S. trademark application, or speak with our attorneys.

Start a new application

(312) 319-4460

Owner

TPI
Chicago, IL
Other trademarks owned by TPI
TPI
Chicago, IL
Other trademarks owned by TPI

Goods and services

Class	Description	Status	First use
005	pharmaceutical preparations for the treatment of autoimmune diseases and autoimmune disorders	ABANDONED	—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Date	Code	Event	What it means
Aug 21, 2013	MAB5	ABANDONMENT NOTICE MAILED - AFTER PUBLICATION	—
Aug 21, 2013	ABN5	ABANDONMENT - AFTER PUBLICATION	—
Aug 19, 2013	EXAR	TEAS EXPRESS ABANDONMENT RECEIVED	—
Aug 19, 2013	TCCA	TEAS CHANGE OF CORRESPONDENCE RECEIVED	—
Mar 26, 2013	ETOF	EXTENSION OF TIME TO OPPOSE RECEIVED	—
Feb 26, 2013	NPUB	OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED	—
Feb 26, 2013	PUBO	PUBLISHED FOR OPPOSITION	Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 6, 2013	NONP	NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED	—
Jan 15, 2013	CNSA	APPROVED FOR PUB - PRINCIPAL REGISTER	—
Jan 15, 2013	DOCK	ASSIGNED TO EXAMINER	—
Oct 4, 2012	NWOS	NEW APPLICATION OFFICE SUPPLIED DATA ENTERED	—

THERAFLIXIMAB